316 related articles for article (PubMed ID: 23175386)
21. Erasers of histone acetylation: the histone deacetylase enzymes.
Seto E; Yoshida M
Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
[TBL] [Abstract][Full Text] [Related]
22. Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes.
Porter NJ; Christianson DW
Methods Enzymol; 2019; 626():561-585. PubMed ID: 31606091
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of a novel human histone deacetylase, HDAC8.
Buggy JJ; Sideris ML; Mak P; Lorimer DD; McIntosh B; Clark JM
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):199-205. PubMed ID: 10926844
[TBL] [Abstract][Full Text] [Related]
24. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
Lombardi PM; Cole KE; Dowling DP; Christianson DW
Curr Opin Struct Biol; 2011 Dec; 21(6):735-43. PubMed ID: 21872466
[TBL] [Abstract][Full Text] [Related]
25. Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8.
Porter NJ; Christianson DW
ACS Chem Biol; 2017 Sep; 12(9):2281-2286. PubMed ID: 28846375
[TBL] [Abstract][Full Text] [Related]
26. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
Vanaja GR; Ramulu HG; Kalle AM
Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
[TBL] [Abstract][Full Text] [Related]
27. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases.
Schultz BE; Misialek S; Wu J; Tang J; Conn MT; Tahilramani R; Wong L
Biochemistry; 2004 Aug; 43(34):11083-91. PubMed ID: 15323567
[TBL] [Abstract][Full Text] [Related]
28. KDAC8 substrate specificity quantified by a biologically relevant, label-free deacetylation assay.
Toro TB; Watt TJ
Protein Sci; 2015 Dec; 24(12):2020-32. PubMed ID: 26402585
[TBL] [Abstract][Full Text] [Related]
29. Active Site Metal Identity Alters Histone Deacetylase 8 Substrate Selectivity: A Potential Novel Regulatory Mechanism.
Castaneda CA; Lopez JE; Joseph CG; Scholle MD; Mrksich M; Fierke CA
Biochemistry; 2017 Oct; 56(42):5663-5670. PubMed ID: 28937750
[TBL] [Abstract][Full Text] [Related]
30. Structures of metal-substituted human histone deacetylase 8 provide mechanistic inferences on biological function .
Dowling DP; Gattis SG; Fierke CA; Christianson DW
Biochemistry; 2010 Jun; 49(24):5048-56. PubMed ID: 20545365
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.
Hu E; Chen Z; Fredrickson T; Zhu Y; Kirkpatrick R; Zhang GF; Johanson K; Sung CM; Liu R; Winkler J
J Biol Chem; 2000 May; 275(20):15254-64. PubMed ID: 10748112
[TBL] [Abstract][Full Text] [Related]
32. Restoring histone deacetylase activity by waste product release. A view from molecular mechanics simulations with mammalian HDAC8.
Pietra F
Chem Biodivers; 2015 Apr; 12(4):503-12. PubMed ID: 25879496
[TBL] [Abstract][Full Text] [Related]
33. HDAC8 Substrates Identified by Genetically Encoded Active Site Photocrosslinking.
Lopez JE; Haynes SE; Majmudar JD; Martin BR; Fierke CA
J Am Chem Soc; 2017 Nov; 139(45):16222-16227. PubMed ID: 29035536
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase 8 regulates cortactin deacetylation and contraction in smooth muscle tissues.
Li J; Chen S; Cleary RA; Wang R; Gannon OJ; Seto E; Tang DD
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C288-95. PubMed ID: 24920679
[TBL] [Abstract][Full Text] [Related]
35. Inhibition and mechanism of HDAC8 revisited.
Chen K; Zhang X; Wu YD; Wiest O
J Am Chem Soc; 2014 Aug; 136(33):11636-43. PubMed ID: 25060069
[TBL] [Abstract][Full Text] [Related]
36. Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors.
Su H; Altucci L; You Q
Mol Cancer Ther; 2008 May; 7(5):1007-12. PubMed ID: 18483291
[TBL] [Abstract][Full Text] [Related]
37. Thermodynamics of binding of structurally similar ligands to histone deacetylase 8 sheds light on challenges in the rational design of potent and isozyme-selective inhibitors of the enzyme.
Singh RK; Suzuki T; Mandal T; Balsubramanian N; Haldar M; Mueller DJ; Strode JA; Cook G; Mallik S; Srivastava DK
Biochemistry; 2014 Dec; 53(48):7445-58. PubMed ID: 25407689
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview.
Banerjee S; Adhikari N; Amin SA; Jha T
Eur J Med Chem; 2019 Feb; 164():214-240. PubMed ID: 30594678
[TBL] [Abstract][Full Text] [Related]
39. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
40. Isoform-selective histone deacetylase inhibitors.
Itoh Y; Suzuki T; Miyata N
Curr Pharm Des; 2008; 14(6):529-44. PubMed ID: 18336298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
